In addition, our results recommended clinicians to take CEA level, M stage, T stage, tumor size, differentiate grade, age and marital status into consideration when estimating the prognosis of mRC patients to help make the optimal treatment and follow-up plan. This evidence concerns the gene CEACAM5 and neoplasm.